Cargando…

A better scoring model for de novo peptide sequencing: the symmetric difference between explained and measured masses

BACKGROUND: Given a peptide as a string of amino acids, the masses of all its prefixes and suffixes can be found by a trivial linear scan through the amino acid masses. The inverse problem is the ideal de novo peptide sequencing problem: Given all prefix and suffix masses, determine the string of am...

Descripción completa

Detalles Bibliográficos
Autores principales: Tschager, Thomas, Rösch, Simon, Gillet, Ludovic, Widmayer, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464308/
https://www.ncbi.nlm.nih.gov/pubmed/28603547
http://dx.doi.org/10.1186/s13015-017-0104-1
_version_ 1783242762627317760
author Tschager, Thomas
Rösch, Simon
Gillet, Ludovic
Widmayer, Peter
author_facet Tschager, Thomas
Rösch, Simon
Gillet, Ludovic
Widmayer, Peter
author_sort Tschager, Thomas
collection PubMed
description BACKGROUND: Given a peptide as a string of amino acids, the masses of all its prefixes and suffixes can be found by a trivial linear scan through the amino acid masses. The inverse problem is the ideal de novo peptide sequencing problem: Given all prefix and suffix masses, determine the string of amino acids. In biological reality, the given masses are measured in a lab experiment, and measurements by necessity are noisy. The (real, noisy) de novo peptide sequencing problem therefore has a noisy input: a few of the prefix and suffix masses of the peptide are missing and a few other masses are given in addition. For this setting, we ask for an amino acid string that explains the given masses as accurately as possible. RESULTS: Past approaches interpreted accuracy by searching for a string that explains as many masses as possible. We feel, however, that it is not only bad to not explain a mass that appears, but also to explain a mass that does not appear. We propose to minimize the symmetric difference between the set of given masses and the set of masses that the string explains. For this new optimization problem, we propose an efficient algorithm that computes both the best and the k best solutions. Proof-of-concept experiments on measurements of synthesized peptides show that our approach leads to better results compared to finding a string that explains as many given masses as possible. CONCLUSIONS: We conclude that considering the symmetric difference as optimization goal can improve the identification rates for de novo peptide sequencing. A preliminary version of this work has been presented at WABI 2016. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13015-017-0104-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5464308
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54643082017-06-09 A better scoring model for de novo peptide sequencing: the symmetric difference between explained and measured masses Tschager, Thomas Rösch, Simon Gillet, Ludovic Widmayer, Peter Algorithms Mol Biol Research BACKGROUND: Given a peptide as a string of amino acids, the masses of all its prefixes and suffixes can be found by a trivial linear scan through the amino acid masses. The inverse problem is the ideal de novo peptide sequencing problem: Given all prefix and suffix masses, determine the string of amino acids. In biological reality, the given masses are measured in a lab experiment, and measurements by necessity are noisy. The (real, noisy) de novo peptide sequencing problem therefore has a noisy input: a few of the prefix and suffix masses of the peptide are missing and a few other masses are given in addition. For this setting, we ask for an amino acid string that explains the given masses as accurately as possible. RESULTS: Past approaches interpreted accuracy by searching for a string that explains as many masses as possible. We feel, however, that it is not only bad to not explain a mass that appears, but also to explain a mass that does not appear. We propose to minimize the symmetric difference between the set of given masses and the set of masses that the string explains. For this new optimization problem, we propose an efficient algorithm that computes both the best and the k best solutions. Proof-of-concept experiments on measurements of synthesized peptides show that our approach leads to better results compared to finding a string that explains as many given masses as possible. CONCLUSIONS: We conclude that considering the symmetric difference as optimization goal can improve the identification rates for de novo peptide sequencing. A preliminary version of this work has been presented at WABI 2016. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13015-017-0104-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-05-11 /pmc/articles/PMC5464308/ /pubmed/28603547 http://dx.doi.org/10.1186/s13015-017-0104-1 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Tschager, Thomas
Rösch, Simon
Gillet, Ludovic
Widmayer, Peter
A better scoring model for de novo peptide sequencing: the symmetric difference between explained and measured masses
title A better scoring model for de novo peptide sequencing: the symmetric difference between explained and measured masses
title_full A better scoring model for de novo peptide sequencing: the symmetric difference between explained and measured masses
title_fullStr A better scoring model for de novo peptide sequencing: the symmetric difference between explained and measured masses
title_full_unstemmed A better scoring model for de novo peptide sequencing: the symmetric difference between explained and measured masses
title_short A better scoring model for de novo peptide sequencing: the symmetric difference between explained and measured masses
title_sort better scoring model for de novo peptide sequencing: the symmetric difference between explained and measured masses
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464308/
https://www.ncbi.nlm.nih.gov/pubmed/28603547
http://dx.doi.org/10.1186/s13015-017-0104-1
work_keys_str_mv AT tschagerthomas abetterscoringmodelfordenovopeptidesequencingthesymmetricdifferencebetweenexplainedandmeasuredmasses
AT roschsimon abetterscoringmodelfordenovopeptidesequencingthesymmetricdifferencebetweenexplainedandmeasuredmasses
AT gilletludovic abetterscoringmodelfordenovopeptidesequencingthesymmetricdifferencebetweenexplainedandmeasuredmasses
AT widmayerpeter abetterscoringmodelfordenovopeptidesequencingthesymmetricdifferencebetweenexplainedandmeasuredmasses
AT tschagerthomas betterscoringmodelfordenovopeptidesequencingthesymmetricdifferencebetweenexplainedandmeasuredmasses
AT roschsimon betterscoringmodelfordenovopeptidesequencingthesymmetricdifferencebetweenexplainedandmeasuredmasses
AT gilletludovic betterscoringmodelfordenovopeptidesequencingthesymmetricdifferencebetweenexplainedandmeasuredmasses
AT widmayerpeter betterscoringmodelfordenovopeptidesequencingthesymmetricdifferencebetweenexplainedandmeasuredmasses